Unicycive Therapeutics (UNCY) executive compensation, 2026 proxy

Shalabh Gupta, M.D., Chief Executive Officer, was paid $2.4M in 2025, down 2% from $2.4M the year before.

Filed
April 30, 2026
Annual meeting
June 19, 2026
Pay year
2025
Named executives
3
CEO total pay
$2.4M-2% vs prior year
CEO Base Salary
$572,000Unchanged from prior year
CEO Option Awards
$1,333,421Grant date fair value
CEO Bonus
$486,200Discretionary bonus

How M.D. was paid

$2.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary24%Bonus20%Option awards56%

Named executive officers

ExecutiveTotal
Shalabh Gupta, M.D.Chief Executive Officer$2,391,621
Pramod Gupta, Ph.D.Executive VP Pharmaceutical and Business Operations$1,036,155
Doug JermasekExecutive VP, Corporate Strategy$481,166

What changed and why

  • $2.4MChief executive officer total compensation decreased to $2,391,621 in 2025 from $2,439,884 in 2024.
  • $1.3MOption awards for the chief executive officer were $1,333,421 in 2025 compared to $1,324,484 in 2024.
  • Discretionary bonuses for named executive officers were determined by the board of directors and paid in December 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.